comparemela.com

Latest Breaking News On - Aboutqualigentherapeutics inc - Page 1 : comparemela.com

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

Qualigen Therapeutics' Pan-RAS Inhibitor Program Highlighted in Two Abstracts at American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Chicago
Illinois
American
Michael-poirier
University-of-louisville-uofl-research-foundation
Qualigen-therapeutics-inc
Jules-abrahamjqa-partners-inc
Qualigen-inc
Aboutqualigentherapeutics-inc
University-of-louisville
American-society-of-clinical-oncology

Qualigen Therapeutics Presents Data On QN-247 in Triple

In Vivo Efficacy Study Demonstrates QN-247 as Potential Therapeutic Approach in Rare Breast Cancer Type CARLSBAD, Calif., April 18, 2023 (GLOBE.

United-states
American
Andrew-hertig
Jules-abraham
Tariq-arshad
Michael-poirier
Markj-sarno
American-association-for-cancer-research
Nasdaq
Aboutqualigentherapeutics-inc
Partners-inc
Qualigen-therapeutics-inc

Composition of Matter Patent for QN-302 Granted by United

CARLSBAD, Calif., March 21, 2023 (GLOBE NEWSWIRE) Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences.

United-states
Jules-abraham
Michael-poirier
Exchange-commission
European-patent-office
Partners-inc
Qualigen-therapeutics-inc
Aboutqualigentherapeutics-inc
Nasdaq
Trademarks-office
Orphan-drug-designation
United-states-patent

Data on Potential Biomarker for Qualigen Therapeutics' Lead Program QN-302 Published in Peer-Reviewed Journal Molecules

Data on Potential Biomarker for Qualigen Therapeutics' Lead Program QN-302 Published in Peer-Reviewed Journal Molecules
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Tariq-arshad
Exchange-commission
Jules-abrahamjqa-partners-inc
Qualigen-therapeutics-inc
Aboutqualigentherapeutics-inc
Nasdaq
Wall-street
Gene-expression-may-be-marker
Anti-tumor-activity
Orphan-drug-designation
Chief-medical-officer

Qualigen Therapeutics Promotes Benedict M. Abugan to Vice President, Head of Diagnostics and Corporate Communications

Qualigen Therapeutics Promotes Benedict M. Abugan to Vice President, Head of Diagnostics and Corporate Communications
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

California
United-states
San-diego
Benedict-abugan
Qualigen-fastpack
Michael-poirier
Benedictm-abugan
University-of-california
Corporate-communications
Jules-abrahamjqa-partners-inc
Qualigen-therapeutics-inc
Aboutqualigentherapeutics-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.